The sale will involve approximately 12.5 million shares and is pegged at a base price of ₹710 per share, representing a 2.5% discount to the current market price, sources close to the development said. Shares of Sai Life Sciences Ltd ended at ₹730, down by ₹8.50, or 1.15%, on the BSE.
